Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants
Clinical trial NCT04212091 · COMPLETED
Trial details
- NCT number
- NCT04212091
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2023-01-18
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.